Our covered call play (CROX) is slightly negative. We bought 500 shares of CROX and sold 5 September $12.50 calls. This is called a “covered call” because we own the stock we are writing the calls against. A “call” gives the purchaser the right, but not the obligation, to buy our CROX shares anytime [...]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read Full Post »
A few weeks ago I wrote about Story Stocks (see “Story Stocks, What’s the Story?). In it I profiled a company called Pro-Pharmaceuticals (PRW), a small biotechnology company that closed at $.67 yesterday.
PRW has a powerful story that is too important to ignore (see their web site). My wife and I attended a session with [...]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read Full Post »
What is a “story stock”? My definition of a story stock is a stock that has no proven product, no earnings, no track record, and generally little money, but has such a compelling product development “story” that, if true and if it ever comes to market, it would revolutionize its industry sector and make millions [...]
Share and Enjoy:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Read Full Post »
